DL-Laudanosine
DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1].
Product Specifications
CAS Number
[1699-51-0]
UNSPSC
12352005
Hazard Statement
H301+H311+H331
Target
Drug Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/dl-laudanosine.html
Purity
99.53
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=CC(CC2N(CCC3=C2C=C(C(OC)=C3)OC)C)=CC=C1OC
Molecular Formula
C21H27NO4
Molecular Weight
357.44
Precautions
H301+H311+H331
References & Citations
[1]V Fodale, et al. Laudanosine, an Atracurium and Cisatracurium Metabolite. Eur J Anaesthesiol. 2002 Jul;19 (7) :466-73.|[2]D J Chapple, et al. Cardiovascular and Neurological Effects of Laudanosine. Studies in Mice and Rats, and in Conscious and Anaesthetized Dogs. Br J Anaesth. 1987 Feb;59 (2) :218-25.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
